Former Aveo exec resigns as ImmunoGen CFO after fraud verdict

The chief financial officer of Waltham-based ImmunoGen has stepped down after a jury found him liable for defrauding investors at his previous company. David Johnston was one of three former Aveo Pharmaceuticals executives accused by the U.S. Securities and Exchange Commission of misleading investors about the Cambridge biotech's ultimately failed effort to secure FDA approval for a kidney cancer drug in 2012 and 2013.

from Biotech News